Down 4.29% to $3.57 on a triple hit: senators sic the FTC on hidden delivery fees, Uber's CEO quits the board, and Grab's own CEO sells 800k shares. Patience expired on a listless small cap with no stop structure — closing the long, out.
Down 3.3% to $28.99, closing through the $29.6 stop — discipline says out, so we're out. Citi, Needham and Stifel all cut targets on margin worries, and a 450k-share related-party forward settlement added real supply. Stopped and closed.
The first of the twin triggers set on 7/17 (intraday $390 break / Monday close under $395) fired on Friday, and discipline says exit before earnings. The 7/2 long closes at a loss — tuition for the second confirmation that a full position into earnings means outsourcing discipline to the gap
The $205 stop broke, so we execute: this long ran from 7/2 with a raised stop, and Kimi K3 plus capex-debt worries are narrative-level headwinds — no re-entry below resistance
Up 1.67% to $19.44. The short banked -28.7% on the month; ahead sit a 7/29 adcomm and an 8/22 PDUFA with 34% of the float short and a record-squeeze history. Holding short into that is gambling, not trading — profits taken, covered.
Down 1.32% to $44.03. The mean-reversion bet never turned: guidance cut, competition, litigation, -31% in three months and 42% below the 200-day. Wrong thesis — closing the long, out.
+4.10%07-04“We drew the $205 stop ourselves last week; Friday closed at $202.81 — discipline has no entry for 'one more day.' Walking away with a profit isn't shameful; pretending the battlefield hasn't changed after the Kimi K3 and DeepSeek-silicon flares went up would be”
Technicals — Friday's near-5% intraday plunge narrowed to -2.21%, showing dip-buyers remain, but the close broke our $205 stop and lost the 50-day ($209.9); the $210 zone flips to resistance, the 200-day at $192.4 is the major line below, and with RSI at 48 direction is a flows story, not a chart story
Fundamentals — The bull narrative faces its first frontal challenge: AI-linked debt financing is estimated in the trillions and PIMCO reckons hyperscaler capex will consume ~94% of operating cash flow; China datacenter revenue is already near zero, so the China angle is sentiment damage rather than revenue damage, while Japan's national AI build-out (a Vera Rubin AI factory with 27,500 Rubin GPUs) shows the demand engine hasn't stalled
News — On 7/17 Moonshot AI released Kimi K3, a 2.8-trillion-parameter open-weights model, triggering a 'new DeepSeek moment' selloff across compute names; Reuters' 7/7 exclusive on DeepSeek designing its own inference silicon kept festering; a Netlist ITC probe into Samsung HBM/DDR5 named Nvidia's supply chain; the 7/16 Cosmos 3 Edge launch and Japan physical-AI expansion failed to stem the slide
Short-term · 1-3 weeks
NeutralSidelines
The $205 stop broke, so we execute: this long ran from 7/2 with a raised stop, and Kimi K3 plus capex-debt worries are narrative-level headwinds — no re-entry below resistance
Entry Flat after the stop-out; a reclaim of the 50-day at $210 with the AI-infra complex stabilizing reopens the case — a low-volume hold of the 200-day at $192 is the alternative checkpointStop —Target —
Long-term · months+
Accumulate
Neither the CUDA moat nor the Rubin roadmap has been dented by any demo chip; the 8/26 print is the next vote of data against narrative
If hyperscaler debt-funded capex tightens, the order slope takes the hit directly
Chinese open-source models keep compressing expected compute intensity
Tail risk if the Netlist ITC probe touches the HBM supply chain
Signal BacktestCumulative +4.10%price itself +2.65%1/1 closed trades wonprofitable since 07-07
07-04Long$194.83 → closed $202.8107-18+4.10%
Community Voices
WSB · Mentions ticked up 95→100 against the tape; the thread topic shifted from 'how much to buy' to 'fold or double down' — faith shaken, not brokenOriginal ↗
Institutional Views
华尔街共识 · 66 analysts average a $313.74 target, +55% from here, with a near-Strong-Buy rating — the sell side hasn't chased the price down yet, and that gap is itself position risk
KeyBanc · Maintained Overweight on 7/14, lifting the target from $310 to $330 — the last hike before the routSource ↗
-9.27%07-07“Of the two trip-wires set last week, $390 burned through on Friday — exiting four days before earnings isn't timidity, it's a signed order coming due. At ±7.6% implied, even market makers are collecting rent rather than picking sides; we don't need to fill a seat at that table”
Technicals — Friday's $380.84 close broke the $390 trigger; the week's -7.2% lost both the 50-day ($409.8) and 200-day ($417), turning the structure bearish. First support sits at the $370 March shelf, and with a $16.9 ATR one earnings-night candle can swallow two weeks of range
Fundamentals — Q2 deliveries of 480,126 set a period record and beat consensus by ~74k units, yet TTM net income is down 47% with a ~4% margin — the price-for-volume bill lands on the income statement. The Street looks for $0.52 EPS on $25.8B revenue, with auto gross margin and the Robotaxi/Optimus timeline the swing factors
News — The SpaceX-merger dream was systematically debunked this week — BNP and others flag 2-3 years of approvals (China included) and one estimate has a no-synergy merger erasing ~$750B of equity value. Meanwhile Robotaxi went driverless in Miami with four more cities slated this year, Optimus' Fremont line readies limited production for late July, and FSD filed for Italian certification
Short-term · 1-2 weeks
NeutralSidelines
The first of the twin triggers set on 7/17 (intraday $390 break / Monday close under $395) fired on Friday, and discipline says exit before earnings. The 7/2 long closes at a loss — tuition for the second confirmation that a full position into earnings means outsourcing discipline to the gap
Entry Trigger executed — flat into the print. Post-7/22, a high-volume reclaim of $400 reopens the long case; losing the $370 shelf points to the $345 areaStop —Target —
Long-term · months+
Neutral
Robotaxi and Optimus are real option value, but auto-margin erosion is the real present; price the options only after the 7/22 cash-flow testimony
A margin miss gapping the stock beyond the ±7.6% implied move
Recurring SpaceX capital-structure rumors whipsawing the valuation anchor
Robotaxi city expansion lagging Morgan Stanley's fleet model
Signal BacktestCumulative -9.27%price itself -10.45%0/1 closed trades won
07-07Long$419.77 → closed $380.8407-18-9.27%
Community Voices
StockTwits · The pre-print retail debate boils down to one line: record deliveries are old news, gross margin is the verdict — bulls and bears agree on volatility, just not directionOriginal ↗
Institutional Views
华尔街共识 · 51 analysts average $407.48, a mere +7% upside, with a 1.77 rating mark, weakest of our deep-dive names and closest to the fence — nobody on the Street dares pick a side into the print
UBS · Raised its target from $364 to $442 on improving demandSource ↗
BNP Paribas · Threw cold water pre-print: a SpaceX merger won't save investors, and Robotaxi/Optimus face brutal two-year KPIsSource ↗
Wells Fargo · Still the Street's bear: target nudged from $125 to $130Source ↗
0.00%07-17“The $69 threshold we drew yesterday missed by five cents at the close — the market said its heaviest line with its smallest spread. Two straight guide-downs strike the word 'one-off' from the bull dictionary; when 17 brokers rewrite targets overnight, count your fingers before you reach for the knife”
Technicals — A 3.3x-volume decline with the 52-week low at $65.08 just 5.6% away says downside momentum hasn't exhausted; RSI 30.7 kisses oversold, but yesterday's rule stands — only a three-day, shrinking-volume reclaim of $69-70 counts as first evidence of seller fatigue, and below $69 the map reads $65
Fundamentals — Q2 revenue of $12.56B (+13.4%) and $0.80 EPS edged past estimates, but growth decelerated from Q1's 16% and operating margin slipped YoY to 33.4%. The ad tier tops 250M MAUs with the $3B ad-revenue-doubling target reaffirmed, and the stock now trades near 24x normalized earnings — cheapest since 2022. Cheap is a fact; an inflection is not
News — The 7/16 print delivered a second consecutive guide-down (Q3 revenue $12.86B vs ~$13.0B, EPS $0.82 vs $0.84) with the full-year band narrowed to $51.0-51.4B; halving engagement disclosure to once a year read as a transparency retreat. At least 17 brokers cut targets the next day, with analysts warning the company is 'losing narrative control'
Short-term · 1-3 weeks
NeutralSidelines
De-ratings through a growth downshift have no precise floor; 24x only matters alongside a stabilizing tape. The summer Upfront ad close is the next tradeable positive catalyst
Entry No catching the second knife: a three-day shrinking-volume reclaim of $70 is the first right-side evidence, while a high-volume break of the $65.08 52-week low voids every dip-buying fantasyStop —Target —
Long-term · months+
Neutral
Ad-revenue doubling and live sports (Women's World Cup / NFL / WWE) form a real second curve, but falling per-member watch time plus the disclosure retreat mean the growth story must re-prove itself
With engagement disclosure reduced, bad news gets confirmed later and at a higher price
YouTube's screen-time squeeze and media-M&A reshaping the competitive map
Lagged churn from the second US price hike
Community Voices
WSB · Mentions halved from 380 to 123 yet aggregate sentiment stays firmly bullish — retail is buying the dip, and the dip-buyers are waiting for the next wave of dip-buyersOriginal ↗
Institutional Views
华尔街共识 · 57 analysts average $102.02, +48% from here, still Buy-skewed with zero Sells — but targets are being slashed in real time, making consensus a moving target
JPMorgan · Kept Overweight but slashed the target from $118 to $85Source ↗
Barclays · Equal Weight, target $85 to $80, saying Netflix is losing narrative controlSource ↗
New today“A 12% EPS beat bought a 14% bloodbath — at 40x, 'in line but no raise' reads as a confession. GLP-1s are stealing patients from bariatrics and ACA lapses from elective schedules; with the close 0.25% off the 52-week low, this isn't a discount, it's a re-quote”
Technicals — A 3.6x-volume marubozu closed at $345.42, a quarter-percent above the $344.55 52-week low; below that there is air to the $320 shelf. The 50-day sits 17% overhead at $417, and while RSI touched 30.2, oversold the day after a crash carries no statistical weight
Fundamentals — Q2 beat on both lines — $2.89B revenue (+19%), $2.80 non-GAAP EPS — with 468 da Vinci placements (246 of them da Vinci 5), Ion procedures +36%, and $8.63B in cash. The trouble is all in growth mix: US procedure growth slowed to ~12% (weakest in years), bariatric volumes fell high-single-digits, and management flagged China competition and pricing pressure by name
News — The 7/16 print beat, but holding the FY da Vinci procedure guide at 13.5%-15.5% 'near the midpoint' translates to a cut in growth-stock pricing language. ACA subsidy expiry deferring insured elective surgeries and GLP-1 pressure on bariatrics are the two structural headwinds, with April's Class II E-brake recall (454 systems) still weighing
Short-term · 1-3 weeks
NeutralSidelines
De-ratings born of 'beat but no raise' typically need 2-3 quarters of data to appeal the verdict; the only short-term trade here is an oversold bounce, sized small with an iron stop
Entry The $344.55 52-week low is the last near support — it must hold with no new low for three sessions before any bounce qualifies; below a reclaim of the earnings gap there is no right-side signalStop —Target —
Long-term · months+
Neutral
The robotic-surgery penetration thesis stands (installed base +12%, Ion +36%, ongoing buybacks), but the US growth downshift and GLP-1/insurance headwinds need digesting — the phase where estimates get cut after the multiple has only begun
If 12% US procedure growth is structural rather than one-off, guidance has further to fall
China tender-style price cuts and domestic robot competition
Recall follow-through and FDA posture
Community Voices
StockTwits · Post-crash the split widened: one camp runs PEG math against $8.6B of cash and calls valuation finally fair, the other asks if 12% US growth is page one of a structural slowdown — nobody is sure, which is the honest part of this levelOriginal ↗
Institutional Views
华尔街共识 · 35 analysts average $508, +47% from here — but that map predates the crash; JPM, Wells and Mizuho have already redrawn targets to the $400-487 range
Wells Fargo · Target slashed from $654 to $487Source ↗
New today“A 45nm demo chip — untaped, unyielded, weights unreleased — vaporized tens of billions off the EDA duopoly in a day; panic never checks the process node. The 7/27 weights drop is the mirror that reveals either K3's substance or the market's overreaction, and at RSI 23.9 nobody dares front-run the answer”
Technicals — RSI 23.9 is the most oversold of today's deep-dive names, with the close under Nvidia's $414.79 entry cost; at 59% of its 52-week range with the 50-day ($471) and 200-day ($454) both overhead, the first bounce resistance is the $414-420 zone. Event-driven breaks obey technicals for bounces, not reversals
Fundamentals — May's raised FY2026 guide and design automation at 80% of Q2 revenue underline how deeply the duopoly is embedded at 2/3nm; the quieter subplot is the 7/7 decision to sunset manufacturing process-control software (EES/FDC) and pivot to high-margin AI design — a transition now colliding with a narrative shock
News — On 7/17 Moonshot disclosed that Kimi K3 ran a full design-to-verification flow on a 45nm, 4mm², 1.46M-cell chip in 48 hours using only open-source EDA — instantly compared to the January 2025 DeepSeek shock. The caveats are equally loud: no tape-out, no yield, no advanced-node signoff, weights and methodology not out until 7/27 — the same day Cadence reports
Short-term · 1-2 weeks
NeutralSidelines
An RSI-23.9 technical bounce can fire any day, but bounces in an event vacuum are rented, not owned; let 7/27 adjudicate the narrative before picking a direction
Entry No position before the 7/27 double event (K3 weights + CDNS earnings) — until then every position is a bet against a black box. If replication fails and the narrative lifts, reclaiming $414 (Nvidia's cost basis) is the right-side signalStop —Target —
Long-term · months+
Neutral
The advanced-node duopoly and Ansys integration didn't evaporate overnight, but 'AI eats EDA pricing power' just graduated from sci-fi to a short thesis that must be rebutted quarterly
If third parties replicate even part of the demo after 7/27, the valuation anchor drops again
Execution risk in sunsetting the manufacturing-software line
An August guide-down would resonate with the narrative shock
Community Voices
SemiWiki · Industry forums are buzzing but engineers are broadly skeptical: between a 45nm open-source library and 2nm signoff lies a decade of engineering debt — engineer calm and trader panic never share a time zoneOriginal ↗
Institutional Views
华尔街共识 · 26 analysts average $569.89, +48% upside on a Buy consensus — all struck pre-crash, so downgrade risk and dip-value coexist
BNP Paribas · Calls to buy the dip: K3 shows capability, but top customers still default to the duopoly for complex designsSource ↗
Bernstein · More guarded: K3 proves Chinese labs can match the US frontier, and the market's instant reaction is broadly rationalSource ↗
Benchmark · The worst-timed desk on the Street: initiated CDNS at Buy ($450) and set a $570 SNPS target the day before the crash, citing duopoly barriersSource ↗
New today“An 88% EPS beat, an all-time high, 2.7x volume — flawless except for one thing: the $369 close now sits above nearly every target on the Street. Halved cat losses and $578M of reserve releases are gifts from the weather, not underwriting genius, and with hurricane season opening in August, we're not here to pay exit liquidity for someone else's rally”
Score6/10Q2 core EPS $10.04 vs 预期 $5.34Combined ratio 83.6（改善 6.7pts）Core ROE 24.9%RSI(14) 75.5
Technicals — A gap-and-go breakout to record highs on 2.7x volume put RSI at 75.5 in overbought territory at 99.6% of the 52-week range; the earnings gap back to the $338 pre-print close is the first pullback checkpoint with a $9.31 ATR. Event-driven breakout days are for watching, not chasing — the entry logic lives at the gap retest
Fundamentals — Q2 net income of $2.21B (+46%) on ~$1.7B of underwriting profit with commercial underwriting income doubling, an 83.6 combined ratio and 24.9% core ROE; yet net written premiums of $11.53B were flat YoY — the CEO refuses to buy growth with price ('a fool's errand'), which earns marks for discipline and costs marks for growth
News — The 7/17 pre-open print crushed: cat losses nearly halved to $518M from $927M, $578M of favorable prior-year reserve development, investment income +14%, and $1.58B returned to holders ($1.31B in buybacks). As the first P&C major to report light cats, it was read as a positive preview for Chubb and Allstate, dragging insurers higher on a crash day
Short-term · 1-3 weeks
NeutralSidelines
Upside from above every Street target relies on forced upgrades and rotation flows, neither of which is forecastable; waiting for the retest is cheaper than betting on inertia
Entry No chasing at RSI 75.5; a low-volume hold of the earnings gap (the $338 area) on a pullback is the second-chance entry for the defensive-rotation tradeStop —Target —
Long-term · months+
Accumulate
24.9% core ROE, pricing discipline and heavy buybacks make a quality compounder for the high-rate plateau — the center of the defensive rotation
The Aug-Sep Atlantic hurricane season is Q3's biggest unknowable
Half the quarter's excess profit came from unrepeatable cat/reserve tailwinds
Flat premium growth, if extended, erodes the multiple
Community Voices
StockTwits · The only victory lap in an AI-unwind week: from 'boring insurer' to 'chaos money-printer' in one earnings report — the sentiment pendulum swings far faster than the underwriting cycleOriginal ↗
Institutional Views
华尔街共识 · 34 analysts average $334.17 — the close now sits ~10% above the consensus target, and the 1.9 rating mark is the weakest on our board; either the sell side gets dragged into upgrades or the price mean-reverts, one of the two
Truist · Initiated at Buy with a $395 target on 7/10 — the Street high pre-print, now the only target the price hasn't caughtSource ↗
Cantor Fitzgerald · Target $335 to $360 on 7/9, OverweightSource ↗
-13.36%07-07“After the stop paid out we said wait for the CXMT sentiment trough — the 7/27 listing is now a week away and Hyperliquid pre-IPO perps trade at a 6x premium: the rival's euphoria is pricing the peak of your fear. Until the $800-806 intraday-low band breaks, this is the observation deck, not the table”
Technicals — Friday's -0.5% closed at $848.95 on cooling volume (1.46x average, well off the crash days); the week's -12% never retested the $806.67 intraday low, leaving $800 plus that low as the first support band. Every rally below a reclaimed 50-day ($933.7) is just a bounce, and with an $85.6 daily ATR, position sizing is worth more than direction calls
Fundamentals — FQ4 guides to $50B±1B revenue, ~86% gross margin and $31±1 EPS; 2026 HBM capacity is sold out with Anthropic's ≥$22B non-cancelable commitment as ballast. But Q3 conventional DRAM contract hikes are set to decelerate from +60% to +13-18% QoQ — that flattening slope is the macro backdrop to this long-squeeze, and the peak-cycle-vs-supercycle fight is at full heat
News — The week's -12% traces to 7/15: CXMT confirmed its STAR-board IPO raising ~RMB 57.9B for a 7/27 listing, compounded by reports (still rumor-grade) that Washington may add unilateral HBM export controls. CXMT's Q1 revenue grew 719% YoY into profitability — the 'China memory rising' narrative weighs on sentiment far more than on current P&L
Short-term · 1-3 weeks
NeutralSidelines
Chips that were up 243% YTD at the peak (now +188%) need a full ownership rotation, and this week's persistent drift says it isn't done. Rumor-grade HBM controls are a second leg down if real, a relief rally if not — no bets while the odds are unreadable
Entry Both re-entry triggers stand: a low-volume hammer with a 7-day-RSI divergence in the $800-806 band, or an outright reclaim of the 50-day at $933 — with CXMT's 7/27 debut (moonshot or break-issue) as the sentiment watershedStop —Target —
Long-term · months+
Accumulate
Sold-out HBM, five-year contracts and the Anthropic commitment give cash-flow visibility unprecedented in memory history; CXMT attacks the multiple, not the order book
CXMT capacity accelerating a conventional-DRAM price peak
Unilateral HBM export controls, if real, hit the highest-margin line
The flattening price slope maturing into a cycle turn
Signal BacktestCumulative -13.36%price itself -17.76%0/1 closed trades wonprofitable since 07-10
07-07Long$984.75 → closed $853.207-17-13.36%
Community Voices
WSB · Mentions of 841→658 still top the board: 'MU $2000 is no longer a meme' faces the top-voted bear post claiming hyperscalers are deploying 40x memory-compression tech — and Burry, for what it's worth, opened a short after the record print. Are you the herd or the lead wolf?Original ↗
Institutional Views
华尔街共识 · 53 analysts average $1,581, +86% from here, near Strong Buy — the canyon between target and tape is itself a measure of how deep the disagreement runs
KeyBanc · Overweight kept, target $1,600 to $1,750 on tightness through 2027 — published the day before the plungeSource ↗
Cantor Fitzgerald · A $2,000 target, among the Street's most aggressive bullsSource ↗
New today“A short's most comfortable days are its most dangerous: RSI 26, 27% of the float short, earnings on a 7/27 countdown — and Nebius next door already demoed what a squeeze fuse looks like, +8% in a day on a $775M loan. Trail the stop down to $28.5 and cover before the print; don't let a month of 44% downside dividend become squeeze fuel”
Technicals — Friday's -2.46% closed at $25.79 off a $24.03 low, with $20 the key support flagged by both media and technicians; RSI 26.4 is deeply oversold yet the downtrend structure is intact (36% below the 50-day). Trail the short's stop from $30 to $28.5 and scale profits under $24
Fundamentals — Roughly $16B of non-cancelable hyperscale leases sound solid until you note the anchor tenant is CoreWeave, itself drowning in leverage questions ($35B debt, $536M quarterly interest) — tenant-credit contagion is this short's core logic. June's $1.59B senior secured notes for Polaris Forge 1's fourth building show the financing dependence hasn't eased
News — The sector's triple headwind persists — Meta Compute turning customer into competitor, CoreWeave leverage angst, the financing-equals-dilution doom loop — but 7/17 delivered the first tourniquet: Nebius closed a $775M non-dilutive GPU-collateralized loan and bounced 8%, while Stocktwits shows retail bottom-fishing all four neocloud names. APLD itself printed no news in July; this is pure sector beta
Short-term · 1 week
ShortBearish
Trend and thesis still point down, but RSI 26.4 plus 27% short interest into earnings makes the risk-reward asymmetric; a Nebius-style non-dilutive financing headline is a reversal button that can be pressed any day
Entry Hold the short, no adds; trail the stop from $30 down to $28.5 and cover proactively before the 7/27 print (by the 7/24 close at latest) — we don't carry shorts through binary eventsStop $28.5Target $20~22
Long-term · months+
Avoid
An asset-heavy, debt-funded model anchored to one credit-questionable tenant offers no margin of safety in an AI-capex contraction
(For the short) a beat-and-raise on 7/27 triggers violent covering
(For the short) new-lease or non-dilutive financing headlines have historically gapped the stock up
Community Voices
StockTwits · Retail is dip-buying all four of NBIS/IREN/CRWV/APLD — a wall of knife-catchers facing 27% short interest, with squeeze kindling piling up on both sidesOriginal ↗
Institutional Views
华尔街共识 · 14 analysts average $73, +183% upside, a perfect 1.0 Strong Buy — unanimous analyst bullishness versus a collapsing tape; one side is swimming naked
S&P Global 汇总 · None of 11 tracked targets sits below $40, topping out at $106 — sell-side models have no line item for tenant-credit contagionSource ↗
Neutral
7
SPCXSpace Exploration Technologies · Space / SatCom
Social BuzzWatchlist
+1.83%07-02“Five straight down days, a post-IPO low, $25B of shorts leaning on 29% of the float — the 7/20 relaunch is a coin flip and 8/6 brings earnings plus a 911M-share unlock guillotine. Every trapped layer above $135 is waiting to sell into every rally; rockets can reignite, cap tables can't”
Technicals — Friday's -5.43% closed at $123.99 off a $122.14 all-time low, with no moving averages yet formed and nothing but the $120 psychological mark and $110 round number below; at a 5.8 beta, every directional view must first be divided by its volatility
Fundamentals — Starlink passed 10.3M subscribers, doubling in a year, with 2025 connectivity revenue above $11B and $4.4B of operating profit — the cash flow is real. So is the valuation dispute: Morningstar's $62-63 fair value says it's still twice too dear, Raymond James' $800 says it's six times too cheap. Same company, two universes
News — Starship Flight 13 aborted at the final second on 7/16 (multiple Raptors failed to light); Musk confirmed two engine swaps with a 7/20 earliest retry — the mission carries the first operational payload of 20 Starlink V3 sats. The stock first broke its $135 IPO price on 7/15, the $4.3B of Nasdaq-100 passive buying is fully digested, and S3 shows shorts adding after the abort
Short-term · 1-3 weeks
NeutralSidelines
Passive flows are spent and active money is waiting out the unlock — no supply-demand fix before 8/6, and a successful-launch rally most likely opens the exit window for trapped longs
Entry The 7/20 launch is a two-way volatility event, not an investment entry; stay flat until the 8/6 unlock is priced, with a break of the $122 listing low pointing to $110Stop —Target —
Long-term · months+
Neutral
Starlink cash flow and Starship launch monopoly are decade-class assets, but a valuation set on a 3-5% float must survive repricing through the full unlock cycle
Supply shock from ~911.5M shares unlocking from the second session after the 8/6 print
Repeated Starship setbacks delaying V3 deployment and the revenue model
Anchor-free valuation with extreme volatility (beta 5.8)
Signal BacktestCumulative +1.83%price itself -21.30%1/1 closed trades wonprofitable since 07-04
07-02Long$157.54 → closed $160.4207-07+1.83%
Community Voices
WSB · Rank 3 on the board (244 mentions, 1,204 upvotes): the crowded $160 calls are deep underwater and the conversation has turned from 'to the stars' to 'what about the 8/6 unlock' — dreams turned into positions are retail's real leverageOriginal ↗
Institutional Views
华尔街共识 · 36 analysts average $240.65, +94% upside on a Buy consensus — but every target predates the IPO break, and pre-unlock targets deserve a haircut
Morgan Stanley · Initiated Overweight with a $300 target at the Nasdaq-100 inclusionSource ↗
Morningstar · The clearest bear: $62-63 fair value, implying the stock is still roughly twice overvaluedSource ↗
Down 0.99% to $743.29 on a day when 8 of 11 sectors rose — the carnage is confined to AI hardware, and defensives are keeping the index respectable(Long-term: Core allocation unchanged; navigate the 7/22-29 earnings-and-FOMC gauntlet with sizing, not forecasts)
Down 1.5% to $695.33, -5.4% on the month — the main theater of the growth unwind; RSI 42 is soft but nowhere near a panic low(Long-term: The long-term case stands, but accept elevated volatility through the AI-capex repricing — keep averaging in, skip the leverage)
Down 1.01% to $683.17 in lockstep with SPY — a broad-index down day is a dollar-cost-averager's restocking day(Long-term: Core holding; a 1.2% weekly dip carries zero information against long-term compounding)
Down 1.02% to $746.72 as all three S&P trackers bled the same 1% — an alpha-free session(Long-term: Interchangeable with SPY/VOO as a core sleeve — hold whichever is cheapest to own)
Only -0.52% to $294.04 — small caps sit farthest from the AI meat grinder, and +0.5% on the month is a rare green number on this board(Long-term: With rate-cut odds whipsawing, don't mistake Russell beta for alpha)
Down 2.18% to $556.53, -7.4% on the week and -12.1% on the month — the SOX bear's direct casualty; any bounce waits on the earnings chain starting 7/27(Long-term: The secular semis story is intact, but let earnings and the FOMC draw this correction's floor — don't buy the middle of the mountain)
Down 1.64% to $521.81, -8.8% on the week, sharing SMH's sickbed; RSI 41 isn't even oversold — semi bottoms aren't drawn by technicals(Long-term: Pick either this or SMH — the long-term thesis is identical)
Down 0.5% to $162.54 after a -10.4% week — the epicenter of SK Hynix's 7/13 -15% crash, with the Kospi circuit-breaker week still echoing(Long-term: Buying Korea here is buying the HBM pricing-power reset — know exactly which leg you're betting on before acting)
Down 0.34% to $8.69, flat on the week — bitcoin didn't blink through an equity rout; whether that's hedge behavior or numbness, the next big red candle will tell(Long-term: -17.4% over three months with roll decay as a hidden tax on holding — take long-term exposure spot-style, not through futures wrappers)
Down 4.54% to $67.53, -10.6% on the week and -17.3% on the month — in a grinding downtrend, 3x leverage bleeds from volatility decay in both directions. A day-trading tool; don't marry it overnight(not for long-term holding)
Down 4.92% to $135.47, -25.7% on the week and -45.2% on the month — a 3x amplifier of the SOX bear; catching this knife means catching three at once(not for long-term holding)
Down 3.18% to $139.05 — even a mild S&P dip bleeds under a 3x lens; halving leverage before an FOMC week is common sense, not cowardice(not for long-term holding)
Up 4.65% to $42.79, +11.2% on the week — the Nasdaq hedge finally paid. But it's a fire extinguisher, not a fireplace: one rally candle torches a week of gains(not for long-term holding)
Up 5.44% to $54.85, +28.5% on the week — the semi bears' festival. Before getting greedy, read its own 3-month bill of -71.5%: right direction, wrong holding period, still zero(not for long-term holding)
Up 1.91% to $277.7. OpenAI network-layer pilot plus pay-per-crawl opens an agentic monetization lane; Scotiabank lifts to outperform, $300. +20% on the month against the AI unwind — stay long.
Off 1.49% to $139.7. The 7/2 GPU-compute futures launch (COIL index) opens an AI financialization line; BofA targets $234. For an exchange, chaos is revenue — stay long.
Down 1.32% to $44.03. The mean-reversion bet never turned: guidance cut, competition, litigation, -31% in three months and 42% below the 200-day. Wrong thesis — closing the long, out.
Down 1.82% to $43.76. Be clear what this is: a left-side bet into a declining-revenue cycle — guidance calls for low-to-mid single-digit declines for three more quarters, Greater China -17%. The $41.5 stop is non-negotiable. Stay long.
Down 2.2% to $181.2, -12% on the week with zero stock-specific news — pure AI de-risking. Wedbush names it top pick at $250 anyway. The $179 floor sits 1.2% below: break it and we walk. Long, on a tight leash.
Up 2.14% to $17.46 against the tape. Post-$1.16B equity raise, delivery guide lifted to 65-70k units; BNP bumps its target $22 to $24. Stop $16.5, earnings 7/30 — stay long.
Up 0.56% to $155.9. UnitedHealth covers Shield from 8/1, a 27th FDA companion-diagnostic approval lands, RBC initiates at a street-high $185. The -4.9% week is routine digestion after a 25% run since 6/8 — stay long.
Down 2.15% to $194.9, -6.2% on the week by HCA association after its guide-down exposed payer-mix risk across hospitals. THC's own Q1 beat and a Moody's upgrade keep the thesis alive — Q2 has to prove the mix. Stay long, conviction trimmed.
Down 4.29% to $3.57 on a triple hit: senators sic the FTC on hidden delivery fees, Uber's CEO quits the board, and Grab's own CEO sells 800k shares. Patience expired on a listless small cap with no stop structure — closing the long, out.
Flat at $39.56, -0.18%. CEO Dovigi is exploring a take-private around $50 — financing is a real question under $7.1B of debt, but the bid talk itself is downside protection. Earnings 7/29; stay long, conviction up.
Up 2.08% to $103.8, fresh off a 7/15 52-week high. Q1 EPS beat by 59%, the D328eco long-term deal is inked, Jefferies lifts to $105. The 7/29 print is the proof point; stop $97, stay long.
Down 3.3% to $28.99, closing through the $29.6 stop — discipline says out, so we're out. Citi, Needham and Stifel all cut targets on margin worries, and a 450k-share related-party forward settlement added real supply. Stopped and closed.
Flat, +0.09% at $78.59 after a -12.4% week — profit-taking off the 75% post-Sephience run, nothing broken; product revenue guide raised to $750-850M. The $77 stop is 2% away: no bounce, discipline takes over. Long, on the line.
Up 5.02% to $5.02 on 0.26x volume — a dead-cat bounce inside a -70% month. Adding the missing discipline line: $6 is the cover level for the short; thin-volume pops don't change the trend. Short below the line.
Up 1.67% to $19.44. The short banked -28.7% on the month; ahead sit a 7/29 adcomm and an 8/22 PDUFA with 34% of the float short and a record-squeeze history. Holding short into that is gambling, not trading — profits taken, covered.
Down 2.63% to $7.41, -45.1% on the month as AI keeps eating the stock-photo business. Trailing stop tightened from $9 to $8.5; RSI 23 oversold is not a reason to cover. Stay short.
Down 9.47% to $330.11 as the K3 shock hammers EDA. RSI 28.6 is oversold but the knife is still falling — Jul 27 earnings collide with the K3 open-weights release. Wait for the turn.
Up 5.07% to $57.80, a dead-cat bounce after a 22% weekly drubbing. Convert deal, launch slip to 2027, rocket-company M&A chatter — three grenades still smoking. A bounce is not a reversal. Not touching it.
Off 1.03% to $495.76. The exit on the $518 break looks better every day — down 8.9% on the week since. Second-fiddle beta keeps taking hits. Watching from the sidelines.
Up 0.64% to $426.09. The three-month +33% repair rally still looks healthy at RSI 57.9, but with no fresh catalyst there is nothing to chase. On watch.
Up 1.77% to $126.41, but one bounce does not change the story: a leveraged trade with the credit rating as collateral, BBB- one notch from junk. Down 32% on the month — not catching it.
Down 3.96% to $81.56 on double volume — even the defensives took a beating. With earnings season closing in, no entries until this red candle explains itself.
Flat at $127.50 (-0.1%). The +11% monthly pharma repair trade is on the right side of the tape, RSI 57.9 not stretched — but no edge to enter here. Just watching.
Up 5.66% to $787.66, the least-damaged of the storage trio at -8.6% on the week — HDD is less levered to NAND/DRAM pricing. Sector beta, no stock-specific tape bomb. Watching the bounce.
Up 2.23% to $477.22 after a 15.4% weekly storage beatdown: DRAM price-hike forecasts trimmed as customers balk at 30% increases, Samsung/Hynix capacity adds looming. The profit-taking stampede after a +159% quarter is not done — not buying the bounce.
Off 0.23% to $136.97. Gold below $4,000 plus the Malartic pit-wall shutdown and a 2026 output guidance cut — double trouble at RSI 29.5. Jefferies upgraded into the weakness; waiting for Jul 29 earnings before touching it.
Down 0.39% to $1,674.06. The data-center MEP contractor is collateral damage in the AI capex scare, off 14% on the month on 2.8x volume — real disagreement. Let the panic wash out first.
Down 5.04% to $303.62, a fifth straight loss for -23.4% cumulative and $17B of market cap gone. A 204x PE is first against the wall in the Hynix contagion, insider selling on top. Pure valuation strangulation, no fundamental break — still not catching it.
Up 0.4% to $67.62, a breather after the space complex bled 35% in a month. RSI 31 says oversold, but a catch needs a catalyst and there is not one. Standing aside.
Up 0.41% to $73.21, the eye of the neocloud storm. Meta flipping from anchor customer to competitor guts the $99B backlog's credibility, with $35B of debt and $536M quarterly interest on top. The financing structure is the whole debate — watching, not playing.
Down 1.99% to $85.62 as uranium cools with the AI-power narrative, off 21% on the month to RSI 28. Oversold is an adjective, not a thesis, until the story comes back. Passing.
Down 1.97% to $301.01, deep in the AI-hardware EMS wreckage at -27% on the month. RSI 31.9 near oversold with no money coming back yet. Talk after it stabilizes.
Down 3.29% to $329.59 on 4x volume — the data-center construction panic has reached the infrastructure contractors. Off 13.5% on the week with the tape still deteriorating. Steering clear.
Up 1.34% to $208.50, the logistics breakout now at 99.8% of its 52-week range with RSI 72.2 running hot. The breakout is real; the risk/reward of chasing is not. Wait for a pullback.
Down 2.95% to $267.36, RF chips guilty by semiconductor association at -28.4% on the month. No stock-specific story, just sector beatings. Revisit when the group finds a floor.
Down 0.91% to $34.78 with quantum off 38.9% on the month — the deleveraging is not over. RSI 26.1 just means speculators trampling each other. Not catching it.
Up 1.29% to $336.41, industrial distribution grinding along its breakout channel with a mild RSI 59.2. Nice chart, no edge — looking good is not a reason to board.
Down 3.47% to $33.62, an intraday 7% bounce fully faded. The $9.7B Microsoft contract is intact — the market is repricing the business model, not the order book. The earlier exit at +10.4% was right; watching the re-rate play out from the sidelines.
Down 6.13% to $43.98 after a double miss (EPS $2.12 vs $2.31 expected), an alumina guidance cut, and Section 232 tariff costs — RSI 24.6. Aluminum itself is holding with LME stocks below 300kt for the first time since 2022; a company problem, not a metal problem. Pass.
Up 0.53% to $126.02 as the defensive rotation pushes the REIT through its breakout, 99.3% of the 52-week range at RSI 63.7. Do not chase the tail of a rotation — wait for the dip.
Flat at $145.01 (+0.01%), consolidating a breakout at 98.7% of its 52-week range with RSI 68.9 warm. Valid breakout, unforgiving entry. Wait for the retest.
Down 1.69% to $19.16, a pullback day after the regional-bank breakout, 3.2x volume showing real hand-changing. Breakout intact, no fresh edge. Watching.
Off 0.78% to $38.19, a breather after a 3.8x-volume breakout in the freight-cycle story, +30.8% in three months. Not chasing a 30% move — pullback first.
Up 4.26% to $42.83 with RSI at a blistering 83.4 after a +28.7% month. Chasing here is volunteering to hold the bag. Enjoy the show from the sidelines.
Up 2.05% to $23.42 on a freakish 15.85x volume spike, thrift-conversion story attached. Until there is a public explanation for that tape, hands off entirely.
Down 1.55% to $14.61, a rest day after +33.5% on the month and +73.5% in three. A name that only showed up after a 70% run earns a watchlist spot, not a chase.
Down 5.64% to $13.06, capping a 23.6% weekly triple-whammy: index-deletion selling, a broken key support, and FCC spectrum timing up in the air. High-beta story stocks have no friends in a risk-off tape. Stay away.
Down 8.34% to $14.50 on 4x volume, a small cap already bleeding 52% over three months now accelerating lower. In a tape like this there are no bargains, only traps. Avoid.
Up 8.04% to $67.49 on 3.2x volume — a squeeze-style melt-up in a small-cap restaurant name, RSI 77.7 at 99.2% of the 52-week range. Squeezes are best watched, not joined.
Up 11.74% to $19.23 on 5.2x volume as the ethanol/biofuel policy trade ignites, +15.5% on the week to RSI 76.4. Policy fires burn out as fast as they start. Watching.
Off 0.33% to $107.79. The defense fluid-systems name's steady +16.5% three-month grind is intact, and 4.84x relative volume is worth noting — but no edge, no trade.
Down 2.42% to $384.19. A +12% month in a small-cap value name with no volume and no story — the least trustworthy kind of rally. Fringe of the watchlist at best.
Off 0.57% to $6.98 after a 32% weekly collapse to RSI 15 — the classic pattern of a CRE-lending REIT blowing up. Catching this knife means catching the grenade. Stay far away.
Flat at $13.24 on 6.2x volume — huge churn, zero progress, at RSI 74.3. Heavy volume with no price response up here is a warning, not an invitation. Watching.
Up 0.9% to $348.83, a rare green close in a down week — the aero-engine safe haven doing its job. Earnings are near; even safe havens get no adds here. Watching.
Down 3.99% to $1,354.82 after a 23.8% weekly storage massacre: the Hynix crash is the new valuation anchor, HBM4 shipments disappointed, and Buffett name-checked the speculation as a casino attached to the church. BofA raised its target to $2,500 anyway. Bulls and bears at a standoff — not picking a side.
Down 1.19% to $184.14, but +8.5% on the month is relative strength in this tape, RSI 53.7 neutral. Community buzz is back; a trade signal is not. Still watching.
Up 8.92% to $13.80 on 1.6x volume as the LNG-export story heats up, +25.5% on the month. RSI 63.5 is not stretched yet, but no chasing until the right side confirms.
Down 0.96% to $14.47. A SPAC leftover up 40.6% on the month on no volume (0.64x) — a rally with nothing underneath it. Firmly on the do-not-touch list.
Down 14.15% to $16.32 on 2.5x volume — textbook micro-cap biotech financing-fear pattern, with dilution priced into a -40.6% three-month slide. Hands off.
Stock Brief 2026-07-18: Daily U.S. & HK Market Analysis Archive · Quant Brief
